Efficient production of recombinant proteins has to rely on intelligent protein expression systems. This is of particular importance if the protein is to be an active ingredient of human or animal drugs. Scil Proteins Production has developed its own set of plasmids, enabling stable
fermentations of
E. coli to be performed without any kind of antibiotic selection pressure, neither necessary during pre-culturing nor during large scale runs. Customers of Scil Proteins Production can license these vector systems for the production of biopharmaceuticals. The plasmids are designed for registration at regulatory authorities and are free of cross-licenses. On request, tailor-made expression systems can be constructed.
